首页> 外文OA文献 >Abortive activation of CD4 T cell responses during competitive priming in vivo
【2h】

Abortive activation of CD4 T cell responses during competitive priming in vivo

机译:体内竞争性启动过程中CD4 T细胞应答的异常激活

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Immunodominance refers to the highly selective peptide reactivity of T cells during an immune response. In this study, we tested the hypothesis that persistence of peptide:class II complexes is one key parameter that selects the final specificity of CD4 T cells. We found that low-stability peptide:class II complexes support the initial priming and expansion of CD4 T cells, but the expansion becomes strikingly aborted in the presence of competitive T cell responses to unrelated peptides. Our experiments revealed that for inhibition to occur, the competitive responses must be initiated by the same antigen presenting cell, and it is not because of competition for MHC binding. These studies not only provide an insight into the events that regulate competitive CD4 T cell priming in vivo, but also provide a previously undescribed conceptual framework to understand the parameters that select the final specificity of the T cell repertoire during pathogen or vaccine-induced immune responses.
机译:免疫优势是指免疫反应期间T细胞的高选择性肽反应性。在这项研究中,我们测试了以下假设:肽:II类复合物的持久性是选择CD4 T细胞最终特异性的关键参数。我们发现低稳定性肽:II类复合物支持CD4 T细胞的初始启动和扩增,但在竞争性T细胞对无关肽反应的存在下,扩增变得异常中止。我们的实验表明,要发生抑制作用,竞争反应必须由相同的抗原呈递细胞启动,而不是因为竞争MHC结合。这些研究不仅提供了对体内调节竞争性CD4 T细胞启动的事件的深入了解,而且还提供了以前未描述的概念框架,以了解在病原体或疫苗诱导的免疫反应过程中选择T细胞库的最终特异性的参数。 。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号